403 related articles for article (PubMed ID: 16700709)
1. Characterisation and molecular epidemiology of extended-spectrum beta-lactamase-producing Enterobacter cloacae isolated from a district teaching hospital in Taiwan.
Yu WL; Cheng KC; Chi CJ; Chen HE; Chuang YC; Wu LT
Clin Microbiol Infect; 2006 Jun; 12(6):579-82. PubMed ID: 16700709
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of extended-spectrum beta-lactamases in Enterobacter cloacae in Taiwan and comparison of 3 phenotypic confirmatory methods for detecting extended-spectrum beta-lactamase production.
Yang JL; Wang JT; Lauderdale TL; Chang SC
J Microbiol Immunol Infect; 2009 Aug; 42(4):310-6. PubMed ID: 19949754
[TBL] [Abstract][Full Text] [Related]
3. SHV-12 extended spectrum beta-lactamase associated with high-level ceftazidime resistance in Enterobacter cloacae isolated from Thailand.
Tansawai U; Boonkerd N; Polwichai P; Dejsirilert S; Niumsup PR
Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):148-54. PubMed ID: 19323047
[TBL] [Abstract][Full Text] [Related]
4. Screening extended-spectrum beta-lactamase production in Enterobacter cloacae and Serratia marcescens using antibiogram-based methods.
Su PA; Wu LT; Cheng KC; Ko WC; Chuang YC; Yu WL
J Microbiol Immunol Infect; 2010 Feb; 43(1):26-34. PubMed ID: 20434120
[TBL] [Abstract][Full Text] [Related]
5. Molecular typing and characterization of extended-spectrum TEM, SHV and CTX-M beta-lactamases in clinical isolates of Enterobacter cloacae.
Biendo M; Manoliu C; Laurans G; Castelain S; Canarelli B; Thomas D; Hamdad F; Rousseau F; Eb F
Res Microbiol; 2008; 159(9-10):590-4. PubMed ID: 18845248
[TBL] [Abstract][Full Text] [Related]
6. Development of a multiplex PCR and SHV melting-curve mutation detection system for detection of some SHV and CTX-M beta-lactamases of Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae in Taiwan.
Chia JH; Chu C; Su LH; Chiu CH; Kuo AJ; Sun CF; Wu TL
J Clin Microbiol; 2005 Sep; 43(9):4486-91. PubMed ID: 16145096
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of extended-spectrum beta-lactamases in isolates of the Enterobacter cloacae complex from German hospitals.
Hoffmann H; Stürenburg E; Heesemann J; Roggenkamp A
Clin Microbiol Infect; 2006 Apr; 12(4):322-30. PubMed ID: 16524408
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and characterization of extended spectrum beta-lactamase-producing Enterobacter cloacae strains in Algeria.
Nedjai S; Barguigua A; Djahmi N; Jamali L; Zerouali K; Dekhil M; Timinouni M
J Infect Dev Ctries; 2013 Nov; 7(11):804-11. PubMed ID: 24240037
[TBL] [Abstract][Full Text] [Related]
9. Occurrence of extended-spectrum beta-lactamases among chromosomal AmpC-producing Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens in Korea and investigation of screening criteria.
Park YJ; Park SY; Oh EJ; Park JJ; Lee KY; Woo GJ; Lee K
Diagn Microbiol Infect Dis; 2005 Apr; 51(4):265-9. PubMed ID: 15808318
[TBL] [Abstract][Full Text] [Related]
10. Outbreak of infection caused by Enterobacter cloacae producing the novel VEB-3 beta-lactamase in China.
Jiang X; Ni Y; Jiang Y; Yuan F; Han L; Li M; Liu H; Yang L; Lu Y
J Clin Microbiol; 2005 Feb; 43(2):826-31. PubMed ID: 15695687
[TBL] [Abstract][Full Text] [Related]
11. Nosocomial outbreak due to extended-spectrum-beta-lactamase- producing Enterobacter cloacae in a cardiothoracic intensive care unit.
Manzur A; Tubau F; Pujol M; Calatayud L; Dominguez MA; Peña C; Sora M; Gudiol F; Ariza J
J Clin Microbiol; 2007 Aug; 45(8):2365-9. PubMed ID: 17581932
[TBL] [Abstract][Full Text] [Related]
12. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
Lewis JS; Herrera M; Wickes B; Patterson JE; Jorgensen JH
Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160
[TBL] [Abstract][Full Text] [Related]
13. Extended-spectrum beta-lactamases in Taiwan: epidemiology, detection, treatment and infection control.
Yu WL; Chuang YC; Walther-Rasmussen J
J Microbiol Immunol Infect; 2006 Aug; 39(4):264-77. PubMed ID: 16926972
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and characterization of extended-spectrum beta-lactamase-producing Enterobacteriaceae isolated in Korean hospitals.
Ko KS; Lee MY; Song JH; Lee H; Jung DS; Jung SI; Kim SW; Chang HH; Yeom JS; Kim YS; Ki HK; Chung DR; Kwon KT; Peck KR; Lee NY
Diagn Microbiol Infect Dis; 2008 Aug; 61(4):453-9. PubMed ID: 18482815
[TBL] [Abstract][Full Text] [Related]
15. Dissemination of ESBL and Qnr determinants in Enterobacter cloacae in Algeria.
Iabadene H; Messai Y; Ammari H; Ramdani-Bouguessa N; Lounes S; Bakour R; Arlet G
J Antimicrob Chemother; 2008 Jul; 62(1):133-6. PubMed ID: 18385142
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of extended-spectrum beta-lactamases produced by clinical isolates of Enterobacter cloacae from a Teaching Hospital in China.
Liu G; Ling BD; Zeng Y; Lin L; Xie YE; Lei J
Jpn J Infect Dis; 2008 Jul; 61(4):286-9. PubMed ID: 18653970
[TBL] [Abstract][Full Text] [Related]
17. Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae nosocomial bloodstream infections in a tertiary care hospital: a clinical and molecular analysis.
Muro S; Garza-González E; Camacho-Ortiz A; González GM; Llaca-Díaz JM; Bosques F; Rositas F
Chemotherapy; 2012; 58(3):217-24. PubMed ID: 22814216
[TBL] [Abstract][Full Text] [Related]
18. Emergence of TEM, SHV, and CTX-M-extended spectrum β-lactamases and class 1 integron among Enterobacter cloacae isolates collected from hospitals of Tehran and Qazvin, Iran.
Peymani A; Farivar TN; Sanikhani R; Javadi A; Najafipour R
Microb Drug Resist; 2014 Oct; 20(5):424-30. PubMed ID: 24684320
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of plasmid-mediated quinolone resistance determinants QnrA, QnrB, and QnrS among clinical isolates of Enterobacter cloacae in a Taiwanese hospital.
Wu JJ; Ko WC; Tsai SH; Yan JJ
Antimicrob Agents Chemother; 2007 Apr; 51(4):1223-7. PubMed ID: 17242140
[TBL] [Abstract][Full Text] [Related]
20. Risk factors and outcome of extended-spectrum β-lactamase-producing Enterobacter cloacae bloodstream infections.
Qureshi ZA; Paterson DL; Pakstis DL; Adams-Haduch JM; Sandkovsky G; Sordillo E; Polsky B; Peleg AY; Bhussar MK; Doi Y
Int J Antimicrob Agents; 2011 Jan; 37(1):26-32. PubMed ID: 21075605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
